HEALTHCARE INNOVATION CONFERENCE

 Wednesday, September 12 2018 

Overview:

 

To ensure a reliable and sustainable healthcare system, it is crucial to accelerate the development, delivery and uptake of innovative approaches and technology that improve patient care.

 

The healthcare innovation forum focused on emerging technologies and biomedical engineering advances to watch in the year ahead. The conference was collocated with the innovation hub at the Global Health exhibition that would feature a demo zone to review products and concepts that have been ear-marked as the game-changers of healthcare.

 

Key topics:

  • A leadership philosophy for innovation

  • Personalised medicine

  • Regenerative medicine and cell-based therapy

  • 3D printed medical devices

  • Applied Artificial Intelligence

  • Population health analytics

Benefits of attending:

  • Develop strategies for recognizing impact of new technologies and innovative medical practices in a health system

  • Implement strategies to manage the incorporation of innovative technology in your organisation

  • Identify innovations in care delivery that improve outcomes and reduce risk of patient complications

  • Improve clinical decision making in your organisation by identifying the innovative solutions tailored to the population’s health needs

  • Explore the impact of immunotherapy, gene therapy and regenerative medicine in the clinical setting

Speakers:

  • Dag Andersson, CEO, Diaverum, Gothenburg, Sweden

  • Klaus Kleinfeld, Board Member, NEOM, Riyadh, KSA

  • Dr Maliha Hashmi, Executive Director, Strategic Partnerships, NEOM, Riyadh, KSA

  • Prof Dr Osama Hamdy, Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Program, Joslin Diabetes Center, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA

  • Dr Sheraz Gul, Head of Drug Discovery, Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Hamburg, Germany

  • Dr Sultan AlSedairy, Research Scientist, Executive Director, King Faisal Specialist Hospital and Research Centre, Riyadh, KSA

  • Prof Tim McLoughlin, Chairman of the Advisory Board, Chair, Biomedical Engineering, Khalifa University Healthcare Engineering Innovation Centre, Abu Dhabi, UAE

SESSION 1: LEADERSHIP IN INNOVATION

10:30 Special address: Healthcare in the new century: From treatment to prevention
Klaus Kleinfeld, Board Member, NEOM, Riyadh, KSA

11:00 Leadership in innovation: What does it take?
Dag Andersson, CEO, Diaverum, Gothenburg, Sweden

11:30 Keynote address: Precision health
Kieran Murphy, President & CEO, GE Healthcare, Boston, Massachusetts, USA

12:00 Break

SESSION 2
Moderator: Dr Maliha Hashmi,
Executive Director, Strategic Partnerships, NEOM, Riyadh, KSA

13:00 STEM CELL AND REGENERATIVE MEDICINE
Prof Dr Jakub Tolar, Dean of the Medical School, Distinguished McKnight Professor, Vice President for Clinical Affairs, University of Minnesota, Delaware, Minnesota, USA

13:30 DISEASE MANAGEMENT: Patient-driven diabetes care of the future in the technology era
Prof Dr Osama Hamdy, Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Program, Joslin Diabetes Center, Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts, USA

14:00 PHARMACOGENOMICS: Therapeutics discovery: From bench to first in-human trials
Dr Sheraz Gul, Head of Drug Discovery, Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Hamburg, Germany

14:30 HUMAN GENOME
Dr Sultan AlSedairy, Research Scientist, Executive Director, King Faisal Specialist Hospital and Research Centre, Riyadh, KSA

15:00 End of conference